Cargando…

Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole

BACKGROUND: Skeletal involvement of Cryptococcus neoformans is infrequent and usually associated with disseminated cryptococcosis or underlying predisposing conditions. We present an atypical case of osteoarticular cryptococcosis in an immunocompetent patient. CASE PRESENTATION: We herein report a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Deus, Guillem, Gómez-Zorrilla, Silvia, Echeverria-Esnal, Daniel, Siverio, Ana, Güerri-Fernandez, Robert, Ares, Jesús, Campillo, Nuria, Letang, Emili, Knobel, Hernando, Grau, Santiago, Horcajada, Juan Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917311/
https://www.ncbi.nlm.nih.gov/pubmed/33658808
http://dx.doi.org/10.2147/IDR.S294299
_version_ 1783657672069873664
author Deus, Guillem
Gómez-Zorrilla, Silvia
Echeverria-Esnal, Daniel
Siverio, Ana
Güerri-Fernandez, Robert
Ares, Jesús
Campillo, Nuria
Letang, Emili
Knobel, Hernando
Grau, Santiago
Horcajada, Juan Pablo
author_facet Deus, Guillem
Gómez-Zorrilla, Silvia
Echeverria-Esnal, Daniel
Siverio, Ana
Güerri-Fernandez, Robert
Ares, Jesús
Campillo, Nuria
Letang, Emili
Knobel, Hernando
Grau, Santiago
Horcajada, Juan Pablo
author_sort Deus, Guillem
collection PubMed
description BACKGROUND: Skeletal involvement of Cryptococcus neoformans is infrequent and usually associated with disseminated cryptococcosis or underlying predisposing conditions. We present an atypical case of osteoarticular cryptococcosis in an immunocompetent patient. CASE PRESENTATION: We herein report a case of bone and soft tissue cryptococcal infection in a 42-year-old male from Pakistan with well-controlled diabetes without other associated immunodeficiencies treated with antifungal therapy without surgical debridement. Furthermore, the patient developed toxidermia due to fluconazole use, so a fluconazole desensitization was performed. Therapeutic management also included the performance of therapeutic drug monitoring of fluconazole plasma concentrations. CONCLUSION: To our knowledge, this is the first case of osteoarticular cryptococcosis treated with this treatment regimen. This strategy may be of interest to try to reduce hospital stay and associated complications.
format Online
Article
Text
id pubmed-7917311
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-79173112021-03-02 Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole Deus, Guillem Gómez-Zorrilla, Silvia Echeverria-Esnal, Daniel Siverio, Ana Güerri-Fernandez, Robert Ares, Jesús Campillo, Nuria Letang, Emili Knobel, Hernando Grau, Santiago Horcajada, Juan Pablo Infect Drug Resist Case Report BACKGROUND: Skeletal involvement of Cryptococcus neoformans is infrequent and usually associated with disseminated cryptococcosis or underlying predisposing conditions. We present an atypical case of osteoarticular cryptococcosis in an immunocompetent patient. CASE PRESENTATION: We herein report a case of bone and soft tissue cryptococcal infection in a 42-year-old male from Pakistan with well-controlled diabetes without other associated immunodeficiencies treated with antifungal therapy without surgical debridement. Furthermore, the patient developed toxidermia due to fluconazole use, so a fluconazole desensitization was performed. Therapeutic management also included the performance of therapeutic drug monitoring of fluconazole plasma concentrations. CONCLUSION: To our knowledge, this is the first case of osteoarticular cryptococcosis treated with this treatment regimen. This strategy may be of interest to try to reduce hospital stay and associated complications. Dove 2021-02-24 /pmc/articles/PMC7917311/ /pubmed/33658808 http://dx.doi.org/10.2147/IDR.S294299 Text en © 2021 Deus et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Deus, Guillem
Gómez-Zorrilla, Silvia
Echeverria-Esnal, Daniel
Siverio, Ana
Güerri-Fernandez, Robert
Ares, Jesús
Campillo, Nuria
Letang, Emili
Knobel, Hernando
Grau, Santiago
Horcajada, Juan Pablo
Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole
title Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole
title_full Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole
title_fullStr Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole
title_full_unstemmed Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole
title_short Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole
title_sort osteoarticular cryptococcosis successfully treated with high-dose liposomal amphotericin b followed by oral fluconazole
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917311/
https://www.ncbi.nlm.nih.gov/pubmed/33658808
http://dx.doi.org/10.2147/IDR.S294299
work_keys_str_mv AT deusguillem osteoarticularcryptococcosissuccessfullytreatedwithhighdoseliposomalamphotericinbfollowedbyoralfluconazole
AT gomezzorrillasilvia osteoarticularcryptococcosissuccessfullytreatedwithhighdoseliposomalamphotericinbfollowedbyoralfluconazole
AT echeverriaesnaldaniel osteoarticularcryptococcosissuccessfullytreatedwithhighdoseliposomalamphotericinbfollowedbyoralfluconazole
AT siverioana osteoarticularcryptococcosissuccessfullytreatedwithhighdoseliposomalamphotericinbfollowedbyoralfluconazole
AT guerrifernandezrobert osteoarticularcryptococcosissuccessfullytreatedwithhighdoseliposomalamphotericinbfollowedbyoralfluconazole
AT aresjesus osteoarticularcryptococcosissuccessfullytreatedwithhighdoseliposomalamphotericinbfollowedbyoralfluconazole
AT campillonuria osteoarticularcryptococcosissuccessfullytreatedwithhighdoseliposomalamphotericinbfollowedbyoralfluconazole
AT letangemili osteoarticularcryptococcosissuccessfullytreatedwithhighdoseliposomalamphotericinbfollowedbyoralfluconazole
AT knobelhernando osteoarticularcryptococcosissuccessfullytreatedwithhighdoseliposomalamphotericinbfollowedbyoralfluconazole
AT grausantiago osteoarticularcryptococcosissuccessfullytreatedwithhighdoseliposomalamphotericinbfollowedbyoralfluconazole
AT horcajadajuanpablo osteoarticularcryptococcosissuccessfullytreatedwithhighdoseliposomalamphotericinbfollowedbyoralfluconazole